Loading
Loading…
Loading…
| # | Company | Status |
|---|---|---|
| 1 | Admitted-Finance | Admitted-Finance |
| 2 | Admitted-Finance | Admitted-Finance |
| 3 | Admitted-Finance | Admitted-Finance |
| 4 | Not Admitted-Fee/PreQual/Technical | Not Admitted-Fee/PreQual/Technical Not Complied with technical specification |
Tender Value
Refer Docs
EMD Value
₹15.2 L
Closing Date
9 Jan 2025, 3:00 pmClosed
DG AND CEO CMSS
CMSS DELHI
Procurement of Sofosbuvir 400mg and Velpatasvir 100mg for NVHCP
2024_CMSS_840156_1
CMSS/PROC/2024-25/NVHCP/042
Open Tender
Drugs and Pharmaceutical Products
CMSS DELHI
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
₹15.2 L
Yes
CMSS DELHI
7 Feb 2025
17 Dec 2024
10 Jan 2025
17 Dec 2024
9 Jan 2025
24 Dec 2024
23 Dec 2024
Sofosbuvir 400mg + Velpatasvir 100mg
Sofosbuvir 400mg + Velpatasvir 100mg (Developmental Tender)
HETERO LABS LIMITED (BID ID -3151736)
Mylan Laboratories Limited (BID ID -3152018)
stage.html
html • 0.03 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid